Human Genes - Sold to the Highest Bidder?
A U.S. federal appeals court has reaffirmed that gene patents are legal in its ruling last week that Myriad Genetics can keep its patent on the BRCA1 and BRCA2 genes.
View ArticleACLU Asks Supreme Court to Rule on Gene Patents
The ACLU has petitioned the Supreme Court for review of a Federal Circuit decision upholding patent eligibility of isolated DNA sequences.
View ArticlePatents for Genetically Engineered Chimps 'Perverse'
A coalition of European public interest groups brands three patents for genetically engineered chimpanzees "perverse."
View ArticleGenetic Profiteering: Scandal of Firm 'Hiding Vital Breast Cancer Data'
Myriad Genetics is accused of deliberately withholding data that could help other scientists to understand cancer genetics, on the grounds that the information is commercially sensitive.
View ArticleEuropean Society of Human Genetics Reprimands Myriad Genetics
Myriad Genetics claims its research data is a trade secret as it pushes for a stronger presence in the European genetic testing market. Experts' responses reflect the ideological divide in the ongoing...
View ArticleE.U. Patents on Transgenic Chimps Challenged
Animal rights activists in Germany are contesting three patents on genetically engineered chimpanzees granted this year by the European Patent Office.
View ArticleMyriad Updates: Clinical Data as Trade Secrets and a Pending Certiorari Decision
An update on the long-running litigation of Myriad Genetics.
View ArticleU.S. Supreme Court to Decide if Human Genes Patentable
The U.S. Supreme Court has agreed to decide whether human genes can be patented.
View ArticleThe Definitive Book on the Strange History of BiDil
Jonathan Kahn's new Race In A Bottle is an extraordinary account of the birth, life, and death(?) of the first drug to receive FDA approval for a specific racial group.
View ArticleGenes, Patents, and Big Business: at 23andMe, are you the Customer or the...
23andMe has raised $50 million from investors and decisively shifted its focus to building and monetizing a giant database of genetic information, rather than satisfying personal curiosity.
View ArticleDeliriousMe: Ownership and Identity in An Age of Genomic Medicine
The question of who owns our bodies
View ArticleGerman Br
The German Federal High Court fully exploited a narrow sliver of discretion granted it by an EU ruling in order to allow a patent on Oliver Br
View ArticleDirect-to-Consumer Genetic Testing: The Dollars are in the Database
23andMe raised $50 million and plans to use it to lower the cost of its spit kit to $99. CEO Anne Wojcicki hopes this will lead to a very valuable database of one million users' genetic information.
View ArticleUK Government's Enthusiasm for GM Not Matched in Developing Nations
Across the world, countries are turning their backs on GM crops; perhaps the coalition in the UK could learn something from them.
View ArticleMoore is Less
A proposal for addressing the profound legal issues raised by induced pluripotent stem cells.
View ArticleCancer Group Loses Federal Court Bid Against Human Gene Patent
A cancer group fighting against the patenting of a human gene linked to breast and ovarian cancer has lost its landmark case in an Australian court.
View ArticleMonsanto, the Court and the Seeds of Dissent
Should Monsanto, or any corporation, have rights to a self-replicating natural product? On Tuesday, the Supreme Court will decide.
View ArticleCan They Patent Your Genes?
This spring, the Supreme Court will hear a case that may well decide whether genes can be patented, and the consequences for American biomedicine could be huge.
View ArticleEric Lander Weighs in on Gene Patenting Case
A leading geneticist has filed an amicus brief arguing that Myriad has patented products of nature, which are ineligible for such protection.
View ArticleWhat Is a Gene And How Does it Apply to the Law? The Supreme Court Still...
DNA was discovered 60 years ago this week, and since then it's been muddling up the legal system.
View Article
